Your Article Summary
Endeavor Drug-Eluting Stent Is First to Receive CE Mark for Treating Acute Coronary Syndrome
Medtronic, 06/02/09
Medtronic, Inc. , announced that its Endeavor drug-eluting stent (DES) is the first and only coronary stent to have received CE Mark approval for treating patients with acute coronary syndrome, which includes unstable angina and acute myocardial infarction, commonly known as heart attack.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Bayer Team wins the “Deutscher Zukunftspreis” awarded by the German President
BayNews International, 12/03/09
Abbott and the Abbott Fund Honored With Corporate Citizenship Award for International Community Service
Abbott, 12/03/09
Abbotts Ibis Technology Named One of the Top Innovations for 2009 by The Scientist
Abbott, 12/03/09
Article Search
Sponsor


See Latest Articles


